ASCOT-LLA: Extending benefits of statins to hypertensive patients
Hypertension and hypercholesterolemia frequently coexist and the interaction of these important risk factors increases cardiovascular risk considerably.1
It is reasonable to expect that lipid lowering would reduce risk of cardiovascular events in hypertensive patients. Indeed, subgroup analyses of large randomized statin trials support this hypothesis.2-7
However, several issues remain:
- What is the blood pressure threshold for lipid-lowering therapy in hypertensive patients? In particular, will lipid lowering benefit those patients whose blood pressure is well controlled or only slightly elevated?
- What is the cholesterol threshold for lipid-lowering therapy in hypertensive patients?
- Hypertension is a stronger risk factor for stroke than hypercholesterolemia. Will lipid lowering provide additional reduction in stroke risk beyond that provided by blood pressure reduction?
References are listed at the end of the Data Alert.
Download 03ASCOT.ppt (6 slides - 1.5MB)